Dileny Technologies (DilenyTech) LLC, an Egypt-based health-tech startup, has received a $160.00 non-equity award. To enhance and expedite breast cancer screening, the fund will be used to extend its AI-Enabled network. The fund was raised from the Information Technology Academy Partnership (ITAC) program associated with the Development Agency for the Information Technology Industry (ITIDA). The fund was received a few months after a US patent for a new AI-enabled image analysis technology was granted to the startup.
“DilenyTech aims to revolutionize breast cancer screening and diagnostic workflow via providing innovative AI assistance for more accurate breast cancer detection and expedited reporting. Thousands of healthcare professionals can access our online platform anytime/anywhere. This shall reduce patients’ suffering due to long waiting time as well asinaccurate diagnosis,” said Dr. Ahmed Ehab Mahmoud, Founder, and chief innovation officer.
A Look At What The Startup Does
Launched in 2018, DilenyTech develops solutions for medical imaging analysis, breast cancer risk assessment, and structured reporting in several medical applications. The company has provided its services to top-tier international health tech companies with active users in 3 different continents. The team combines both professional and scientific experience with +15 years, and +90 scientific publications, and 3 US patents.
Charles Rapulu Udoh
Charles Rapulu Udoh is a Lagos-based lawyer who has advised startups across Africa on issues such as startup funding (Venture Capital, Debt financing, private equity, angel investing etc), taxation, strategies, etc. He also has special focus on the protection of business or brands’ intellectual property rights ( such as trademark, patent or design) across Africa and other foreign jurisdictions.
He is well versed on issues of ESG (sustainability), media and entertainment law, corporate finance and governance.
He is also an award-winning writer
Dileny